PM hints pharma could avoid ‘value-based’ pricing
March 9, 2007Sales and Marketing PPRS, Tony Blair, value based pricing, value-based pricing
Tony Blair has suggested that the government will not accept value-based pricing of pharmaceutical products as proposed by the Office …
GSK to test Tycerb for head and neck cancer
March 7, 2007Sales and Marketing breast cancer
GlaxoSmithKline is to trial its potential blockbuster Tycerb for a new indication in head and neck cancer.Tycerb was only submitted …
Merck lung cancer vaccine enters phase III trials
March 7, 2007Research and Development
A therapeutic vaccine for the most common form of lung cancer has enrolled its first patient into global phase III …
Academy launched to fill NHS training need
March 7, 2007NHS
Training and development company Excel Communications has launched a new initiative to allow pharma companies to sponsor courses for doctors.The …
Eisai prepares for Inovelon UK launch
March 7, 2007Sales and Marketing
Eisai is preparing to launch its new epilepsy treatment Inovelon in the UK after European regulators approved it in January.Managing …
Work begins on Eisai’s Knowledge Centre
March 7, 2007Research and Development, Sales and Marketing
Eisai is a step nearer to getting its £100 million European base up and running after it broke ground at …
Pfizer’s controversial new UK supply chain goes live
March 5, 2007Manufacturing and Production
Pfizer has launched its new single wholesaler supply chain in the UK, after a last-minute legal challenge was defeated.The pharmaceutical …
PR: messages from the frontline
March 5, 2007Medical Communications, Sales and Marketing public relations, strategy
Media rationalisation & technology"Here is the news but not as we know it! The media landscape is constantly evolving as …
Prime Minister opens Amgen European R&D centre
March 2, 2007Research and Development
Prime Minister Tony Blair has opened Amgen's new European Development Centre in Uxbridge, London.The centre is the Californian biotech company's …
Sales data specialists Cegedim to buy rivals Dendrite
March 2, 2007Sales and Marketing Cegedim
French specialist pharmaceutical database and software company Cegedim is to buy its US-based rivals Dendrite for $751 million.Dendrite's board of …
New clinical trials network to boost patient recruitment in UK
March 2, 2007Research and Development
Thousands more patients are set to be enrolled on clinical trials in primary care in the UK, thanks to the …
Novartis’ 2-in-1 blood pressure drug Exforge launched in the UK
March 2, 2007Sales and Marketing
Novartis new hypertension drug Exforge has been launched in the UK, promising to help more patients lower their blood pressure …
Court orders withdrawal of generic Lipitor in Denmark
March 2, 2007Sales and Marketing
Pfizer has gained a court injunction ordering the withdrawal of a generic version of its top-seller Lipitor (atorvastatin).Indian generics company …
Two products fuelling Actelion’s growth spurt
March 2, 2007Sales and Marketing
Swiss specialist pharma company Actelion saw sales revenue rise 43% in 2006 thanks to rapid growth in its two products, …
US approval for Shire’s Vyvanse
February 28, 2007Sales and Marketing
Shire and New River Pharmaceuticals have been given the green light by the FDA to market anti-ADHD drug Vyvanse. Shire, …
Helping UK pharma communicate
February 28, 2007Medical Communications, Sales and Marketing HCA, assocation, public relations
The Healthcare Communications Association (HCA), which aims to promote excellence and best practice within pharmaceutical industry communications, has reached its …
Radical overhaul of NHS prescription drug prices recommended
February 20, 2007Sales and Marketing pricing
The Office of Fair Trading wants to reform the way prescription medicines are priced to reflect the benefits they bring …
Learning from Northwick Park
February 19, 2007Research and Development UK, biotech, clinical trials, drug safety
In December 2006, the official report on the Northwick Park incident was published. Although not the end of the affair, …
Doctors attack ‘nonsensical’ NHS cost-cutting
February 19, 2007The British Medical Association has branded as "nonsensical" the situation whereby hospitals delay routine operations because of financial problems.The doctors' …
Pfizer to submit evidence to NICE inquiry
February 16, 2007Sales and Marketing
Pfizer has confirmed that it is to submit evidence to a forthcoming inquiry into the workings of NICE.The Commons Health …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
